Skip to main content
ELMD logo

Electromed, Inc. (ELMD) Stock: Price, Forecast & Analyst Target

Electromed, Inc. (ELMD) — MoonshotScore 87/100 (Exceptional band), calculated Nov 18, 2026. Price $22.98 (-1.20%), as of the Nov 20, 2026 trading session; market cap $188M.

Educational signal · not a buy or sell recommendation · How to read this

$22.98 −$0.28 (-1.20%) Market Cap $188M

Electromed, Inc. · ELMD

Electromed, Inc. specializes in developing, manufacturing, and marketing airway clearance therapy products. Their primary focus is on high-frequency chest wall oscillation (HFCWO) technology for patients with compromised pulmonary function.

Price as of Nov 20, 2026

Key Statistics

87 of 100

MoonshotScore v2 · Electromed (ELMD)

Exceptional
Business Quality Elite (94)
Financial Safety Fortress (98)
Valuation Fair (66)
Growth Durability Compounding (93)
Momentum Slipping (39)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality, a fortress balance sheet and elite growth, with no real weak spot — fairly priced, so not a bargain entry. Business Quality: Elite; Financial Safety: Fortress; Valuation: Fair; Growth Durability: Compounding; Momentum: Slipping.

  • EPS beat 8 of the last 8 reports
  • Altman Z 16.69 · Piotroski F 7
  • ROE 24.5% · ROA 16.0% · current ratio 7.19

Helping: business quality, balance-sheet strength, durable growth

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ELMD (58 recorded, newest six shown)
RecordedScoreBand
88Exceptional
87Exceptional
87Exceptional
87Exceptional
87Exceptional
87Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$22.98
Change on the day-1.20%
52-week range$22.98 – $47.40
Market capitalisation$188M—
Price / earnings (trailing)16.06
Shares traded on the day80.8K

Price & events

Other perspectives

Council score for Electromed (ELMD): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Strong
Financial Safety Strong
Valuation Moderate
Growth Durability Strong
Momentum Weak

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Nov 21, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Moderate
Margin of Safety Undervalued
Profit Margin Moderate
Debt/Equity Strong
ROE Strong
Gross Margin Strong

Read on: Nov 21, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

One of these lenses reads this company less favourably than the MoonshotScore does: Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as undervalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Electromed (ELMD), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Electromed, Inc. (ELMD) is the company analyzed here. It employs 196 people and is led by James L. Cunniff. The market values it at $188M.

2 · Latest results

What do the latest results show for Electromed (ELMD)?

Short answer · as of

Against analyst estimates the company has EPS beat 8 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$17M$2M$0.25 (diluted)
Q2 FY2026$19M$3M$0.32 (diluted)
Q3 FY2026$19M$3M$0.35 (diluted)
Q4 FY2026$19M$3M$0.39 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Electromed (ELMD)?

Short answer

The MoonshotScore pillars rate business quality, balance-sheet strength, durable growth as strengths. The distress and quality screens read Altman Z 16.69 · Piotroski F 7. Trailing ratios: ROE 24.5% · ROA 16.0% · current ratio 7.19.

4 · What to check next?

What should you watch next at Electromed (ELMD)?

Short answer · as of

Current published price targets run low $47.00 · high $50.00 · consensus $48.50 · median $48.50 against a quoted price of $22.98 (as of Nov 20, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Electromed compare with its peers?

Short answer

Electromed's score ranks tied for 3rd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Tactile Systems Technology, Inc. (TCMD) Same industry, near in market value$25.60 Nov 20, 2026$573M90 5-pillar Nov 18, 2026
Viemed Healthcare, Inc. (VMD) Same industry, near in market value$8.52 Nov 20, 2026$323M88 5-pillar Nov 18, 2026
Electromed (ELMD) — this page$22.98$188M87
BrainsWay Ltd. (BWAY) Same industry, near in market value$8.73 Nov 19, 2026$351M87 5-pillar Nov 18, 2026
Anika Therapeutics, Inc. (ANIK) Same industry, near in market value$13.23 Nov 20, 2026$177M71 5-pillar Nov 18, 2026
LENSAR, Inc. (LNSR) Same industry, near in market value$4.64 Nov 19, 2026$57.1M44 5-pillar Nov 18, 2026
Solana Company (HSDT) Same industry, near in market value$1.49 Nov 20, 2026$93.7M43 5-pillar Nov 18, 2026
Owlet, Inc. (OWLT) Same industry, near in market value$3.23 Nov 19, 2026$96.5M41 5-pillar Nov 18, 2026
Inogen, Inc. (INGN) Same industry, near in market value$5.30 Nov 20, 2026$138M37 5-pillar Nov 18, 2026
Orthofix Medical Inc. (OFIX) Same industry, near in market value$6.07 Nov 20, 2026$247M36 5-pillar Nov 18, 2026
Viatris Inc. (VTRS) Named competitor$19.63 Nov 20, 2026$22.5B35 5-pillar Nov 18, 2026
908 Devices Inc. (MASS) Same industry, near in market value$8.67 Nov 20, 2026$361M35 5-pillar Nov 18, 2026
Sight Sciences, Inc. (SGHT) Same industry, near in market value$10.18 Nov 20, 2026$566M34 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$47.00 – $50.00
Consensus target
$48.50
Median target
$48.50

Consensus record · Captured .

Measured against a quoted price of $22.98 (as of Nov 20, 2026).

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Sep 1, 2026

Transactions
16
Identified insiders
2
Purchases
0
Sales
5
Other transactions
11

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ELMD in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ELMD in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Electromed (ELMD)?

Read these with our analysis →

Investor Questions: ELMD Stock

These answers are editorial: 2 of these 9 answers are drawn from the ELMD research dossier (written May 6, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for ELMD?

ELMD carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Electromed, Inc. specializes in developing, manufacturing, and marketing airway clearance therapy products.

Is ELMD a good stock to buy?

Stock Expert AI does not rate ELMD buy, sell or hold. Electromed, Inc. carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ELMD stock price today?

The last price recorded for Electromed, Inc. (ELMD), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the ELMD price target?

The analyst consensus price target for Electromed, Inc. (ELMD), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What revenue streams does Electromed, Inc. have in healthcare?

Electromed, Inc.'s primary revenue stream is the sale of its SmartVest Airway Clearance Systems, which utilize High Frequency Chest Wall Oscillation (HFCWO) technology. These systems are sold to both the home healthcare market and acute care settings. Revenue is generated through direct sales to patients, healthcare providers, and hospitals.

How does Electromed, Inc. differentiate itself from competitors in the respiratory therapy market?

Electromed, Inc. differentiates itself through its focus on High Frequency Chest Wall Oscillation (HFCWO) technology and its SmartVest system. The SmartVest system is designed for patient comfort and ease of use, promoting adherence to therapy.

What are the key factors to evaluate for ELMD?

Electromed, Inc. (ELMD) holds a MoonshotScore in the high range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. By targeting specific regions with high unmet needs for airway clearance therapy, the company can diversify its revenue streams and reduce its reliance on the U.S. market. Not financial advice.

How frequently does ELMD data refresh on this page?

ELMD's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ELMD's recent stock price performance?

Electromed, Inc. (ELMD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary HFCWO technology. See the News tab for the latest drivers. Past performance does not predict future results.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 6, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 10 from Financial Modeling Prep (FMP), 7 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.